RUDMAN ERROL M - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 83 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2018. The put-call ratio across all filers is 2.06 and the average weighting 0.4%.

Quarter-by-quarter ownership
RUDMAN ERROL M ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2019$5,293,000
+20.2%
58,0000.0%3.57%
+16.3%
Q4 2018$4,403,000
-31.2%
58,000
-27.5%
3.07%
+28.6%
Q3 2018$6,400,000
-99.3%
80,000
+823.1%
2.39%
+495.8%
Q2 2018$860,794,000
+49801.1%
8,666
-59.3%
0.40%
-51.6%
Q1 2018$1,725,000
-23.7%
21,301
-25.8%
0.83%
-24.5%
Q4 2017$2,261,000
-8.9%
28,701
+6.7%
1.10%
-23.0%
Q3 2017$2,482,00026,9011.42%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q3 2018.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders